Results 131 to 140 of about 372,893 (296)

A Declining Trend of 'Leishmaniasis' Based on Previous Data in Larstan, South of Iran 2007–2017

Annals of Global Health, 2019
Introduction: 'Cutaneous Leishmaniasis' is a unicellular of the Leishmania type, and 0.7 to 1.2 million people are annually infected by 'Cutaneous Leishmaniasis'. Larestan is one of the southern cities of Fars Province.
Ahmad Abolghazi, Forough Ebrahimizadeh, Fatemh Sharafi, Naser Hatami, Zahra Vafai   +4 more
doaj   +1 more source

Management of trypanosomiasis and leishmaniasis [PDF]

, 2012
<p>Background: The current treatments for human African trypanosomiasis (HAT), Chagas disease and leishmaniasis (collectively referred to as the kinetoplastid diseases) are far from ideal but, for some, there has been significant recent progress ...
Alsford, Alvar, Alvar, Barrett, Barrett, Ben Salah, Berman, Bern, Brun, Brun, Burri, Chappuis, Coura, Croft, Croft, El-Sayed, Frearson, Hailu, Jacobs, Jacobs, Le Loup, Lessa, M. P. Barrett, Miranda-Verastegui, Paine, Pinazo, Priotto, Rassi, Reithinger, Rodgers, S. L. Croft, Stuart, Sundar, Sundar, Sundar, Sundar, Torreele, Vanhollebeke, Vincent, Voogd   +39 more
core   +2 more sources

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Acta Medica Iranica, 2019
The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (
Reza Boostani, Pouran Layegh, Mohammad Javad Yazdanpanah, Elham Vosoughi, Azadeh Mohammadi, Noseibe Joneidi, Reyhaneh Bazargani, Delaram Sayadpour Zanjani, Saeed Ebrahimzadeh   +8 more
doaj  

Symmetrical Cutaneous Leishmaniasis

Acta Dermato-Venereologica, 2005
Sir, Cutaneous leishmaniasis (CL) is a protozoan disease present in Old and New Worlds (1, 2). It is endemic in the Mediterranian basin, particularly in the rural areas of Sicily where almost 60% of Italian cases occur. The disease is caused by parasites of the genus Leishmania infantum, carried by specific species of sandflies as Phlebotomus ...
GUARNERI, Claudio, GUARNERI, Fabrizio Nicola Giuseppe   +1 more
openaire   +3 more sources

Cutaneous Leishmaniasis and Conflict in Syria

Emerging Infectious Diseases, 2016
To the Editor: War, infection, and disease have always made intimate bedfellows, with disease recrudescence characterizing most conflict zones (1). Recently, increasing violence from civil war and terrorist activity in the Middle East has caused the ...
Waleed S. Al-Salem, D. Pigott, Krishanthi S Subramaniam, L. Haines, L. Kelly-Hope, D. Molyneux, Simon Iain Hay, Á. Acosta-Serrano   +7 more
semanticscholar   +1 more source

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran

Case Reports in Infectious Diseases, 2015
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah, Masumeh Rassaei, Fatemeh Sari aslani   +2 more
doaj   +1 more source

Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective study

Scientific Reports, 2016
Leishmaniases are tropical zoonotic diseases, caused by kinetoplastid parasites from the genus Leishmania. New World (NW) species are related to sylvatic cycles although urbanization processes have been reported in some South American Countries such as ...
J. Ramírez, C. Hernández, C. León, M. Ayala, C. Flórez, Camila González   +5 more
semanticscholar   +1 more source

Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation [PDF]

, 2006
Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but Leishmania species and strain differences are important.
A Schriefer, AL Bañuls, B Rotureau, CM Lucas, D Evans, D McMahon-Pratt, E Cupolillo, E Cupolillo, E Handman, E Handman, EA Gomez, Eduardo A Gomez, F Pratlong, H Yamasaki, Hiroshi Uezato, Hirotomo Kato, J Convit, JB Alexander, JC Dujardin, JC Dujardin, JD Marco, JJ Shaw, Jorge D Marco, M Calvopina, M Calvopina, M Chico, M Furuya, Manuel Calvopina, Masataka Korenaga, NE Reiner, NG Saravia, P Jaccard, Paola A Barroso, Philip J Cooper, RD Kreutzer, Rodrigo X Armijos, RX Armijos, RX Armijos, S Kumar, S Nonaka, SB Abderrazak, Shigeo Nonaka, T Mimori, Tatsuyuki Mimori, World Health Organization, Y Hashiguchi, Y Hashiguchi, Y Hashiguchi, Yoshihisa Hashiguchi   +48 more
core   +3 more sources

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea

PLoS Neglected Tropical Diseases, 2017
Background Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong potential for a solid clinical benefit in this indication.
R. Guery, B. Henry, G. Martin-Blondel, C. Rouzaud, F. Cordoliani, G. Harms, J. Gangneux, F. Foulet, E. Bourrat, M. Baccard, G. Morizot, P. Consigny, A. Berry, J. Blum, O. Lortholary, P. Buffet   +15 more
semanticscholar   +1 more source

Clinical pattern and treatment outcome of cutaneous leishmaniasis patients in Somali region, eastern Ethiopia

Skin Health and Disease
Background Neglected tropical diseases, affecting over a billion people, include leishmaniasis, a protozoan parasite found in over 20 species. It is classified into three types: visceral, cutaneous, and muco‐cutaneous leishmaniasis, with cutaneous ...
Abdilahi Ibrahim Muse, Muse Obsiye Ibrahim, Muse Ahmed Ibrahim   +2 more
doaj   +1 more source